ReP USP - Resultado da busca

Artigo de periodico
Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges (2022)
Rossi, Giordano Novak; Hallak, Jaime Eduardo Cecilio ; Saiz, José Carlos Bouso; Santos, Rafael Guimarães dos
Source: Expert Opinion on Drug Safety. Unidade: FMRP
Subjects: ANTIDEPRESSIVOS, FÁRMACOS PSICOTRÓPICOS, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROSSI, Giordano Novak et al. Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges. Expert Opinion on Drug Safety, v. 21, n. 6, p. 761-776, 2022Tradução . . Disponível em: https://doi.org/10.1080/14740338.2022.2066650. Acesso em: 02 out. 2024.
APA
Rossi, G. N., Hallak, J. E. C., Saiz, J. C. B., & Santos, R. G. dos. (2022). Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges. Expert Opinion on Drug Safety, 21( 6), 761-776. doi:10.1080/14740338.2022.2066650
NLM
Rossi GN, Hallak JEC, Saiz JCB, Santos RG dos. Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges [Internet]. Expert Opinion on Drug Safety. 2022 ; 21( 6): 761-776.[citado 2024 out. 02 ] Available from: https://doi.org/10.1080/14740338.2022.2066650
Vancouver
Rossi GN, Hallak JEC, Saiz JCB, Santos RG dos. Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges [Internet]. Expert Opinion on Drug Safety. 2022 ; 21( 6): 761-776.[citado 2024 out. 02 ] Available from: https://doi.org/10.1080/14740338.2022.2066650
Artigo de periodico
Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature (2019)
Rocha, Juliana M.; Osório, Flávia de Lima ; Crippa, José Alexandre de Souza ; Bouso, José Carlos; Rossi, Giordano Novak ; Hallak, Jaime Eduardo Cecilio ; Santos, Rafael Guimarães dos
Source: Therapeutic Advances in Psychopharmacology. Unidade: FMRP
Subjects: ALUCINOGÊNICOS, EXPRESSÃO CORPORAL, FACE, EMOÇÕES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, Juliana M. et al. Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature. Therapeutic Advances in Psychopharmacology, v. 9, p. 1-11, 2019Tradução . . Disponível em: https://doi.org/10.1177/2045125319845774. Acesso em: 02 out. 2024.
APA
Rocha, J. M., Osório, F. de L., Crippa, J. A. de S., Bouso, J. C., Rossi, G. N., Hallak, J. E. C., & Santos, R. G. dos. (2019). Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature. Therapeutic Advances in Psychopharmacology, 9, 1-11. doi:10.1177/2045125319845774
NLM
Rocha JM, Osório F de L, Crippa JA de S, Bouso JC, Rossi GN, Hallak JEC, Santos RG dos. Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature [Internet]. Therapeutic Advances in Psychopharmacology. 2019 ; 9 1-11.[citado 2024 out. 02 ] Available from: https://doi.org/10.1177/2045125319845774
Vancouver
Rocha JM, Osório F de L, Crippa JA de S, Bouso JC, Rossi GN, Hallak JEC, Santos RG dos. Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature [Internet]. Therapeutic Advances in Psychopharmacology. 2019 ; 9 1-11.[citado 2024 out. 02 ] Available from: https://doi.org/10.1177/2045125319845774
Artigo de periodico
Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer (2019)
Santos, Rafael Guimarães dos ; Bouso, José Carlos; Hallak, Jaime Eduardo Cecilio
Source: BMC Psychiatry. Unidade: FMRP
Subjects: PSIQUIATRIA, ONCOLOGIA, NEOPLASIAS, DEPRESSÃO, ANSIEDADE, ALUCINOGÊNICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Rafael Guimarães dos e BOUSO, José Carlos e HALLAK, Jaime Eduardo Cecilio. Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer. BMC Psychiatry, v. 19, p. art. 321 [4] , 2019Tradução . . Disponível em: https://doi.org/10.1186/s12888-019-2288-z. Acesso em: 02 out. 2024.
APA
Santos, R. G. dos, Bouso, J. C., & Hallak, J. E. C. (2019). Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer. BMC Psychiatry, 19, art. 321 [4] . doi:10.1186/s12888-019-2288-z
NLM
Santos RG dos, Bouso JC, Hallak JEC. Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer [Internet]. BMC Psychiatry. 2019 ; 19 art. 321 [4] .[citado 2024 out. 02 ] Available from: https://doi.org/10.1186/s12888-019-2288-z
Vancouver
Santos RG dos, Bouso JC, Hallak JEC. Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer [Internet]. BMC Psychiatry. 2019 ; 19 art. 321 [4] .[citado 2024 out. 02 ] Available from: https://doi.org/10.1186/s12888-019-2288-z
Artigo de periodico
Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews (2018)
Santos, Rafael G. dos; Bouso, José Carlos; Alcázar-Córcoles, Miguel Ángel; Hallak, Jaime Eduardo Cecílio
Source: Expert Review of Clinical Pharmacology. Unidade: FMRP
Subjects: TRANSTORNOS DA ANSIEDADE, ANSIOLÍTICOS, SEROTONINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Rafael G. dos et al. Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews. Expert Review of Clinical Pharmacology, v. 11, n. 9, p. 889-902, 2018Tradução . . Disponível em: https://doi.org/10.1080/17512433.2018.1511424. Acesso em: 02 out. 2024.
APA
Santos, R. G. dos, Bouso, J. C., Alcázar-Córcoles, M. Á., & Hallak, J. E. C. (2018). Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews. Expert Review of Clinical Pharmacology, 11( 9), 889-902. doi:10.1080/17512433.2018.1511424
NLM
Santos RG dos, Bouso JC, Alcázar-Córcoles MÁ, Hallak JEC. Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews [Internet]. Expert Review of Clinical Pharmacology. 2018 ; 11( 9): 889-902.[citado 2024 out. 02 ] Available from: https://doi.org/10.1080/17512433.2018.1511424
Vancouver
Santos RG dos, Bouso JC, Alcázar-Córcoles MÁ, Hallak JEC. Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews [Internet]. Expert Review of Clinical Pharmacology. 2018 ; 11( 9): 889-902.[citado 2024 out. 02 ] Available from: https://doi.org/10.1080/17512433.2018.1511424

USP Schools

ReP

Filtros

Authors

Subjects

Funding Agencies

Indexado em